Korean Biotech Startups
Organized by Sujin Lee, from the Korean-German Chamber of Commerce and Industry, AHK Korea, https://korea.ahk.de/en/, and with my colleagues from Bayer Radhika Das Chakraborty, Min Wei, Pei Sze Ng, Min Pang, John-Edward Butler-Ransohoff, and Joerg Knaeblein, we had yesterday a wonderful get-to-know session with Korean Biotechnology startups.
I love these meetups where you learn a lot about what others are doing, exchange, and open your mind about new science. Amazing.
AUTOTAC Bio, http://www.autotacbio.com/eng/company/index.php. Founded 2018, they are working on a new approach for proteolysis targeting chimera, called AutoTac, focusing on neurodegenerative diseases, amyloidosis, certain cancers and rare diseases.
G+FLAS Life Sciences, http://eng.gflas.com/en/about/gflas.php. Founded 2014, HQs in Seoul. They are working on a novel gene editing platform, using their enhanced CRISPR-PLUS technology.
LyseNTech, http://www.lysentech.com/. Founded 2019, headquartered in Gyeonggi-Do, the area surrounding Seoul. They are using Bacteriophages developed from the Bacteriophage Bank of Korea to target bacteria or cancer cells.
OneGene Biotechnology, https://www.onegenebt.com/. Founded 2016, headquartered in Gyeonggi-Do. With a proprietary protein-protein conjugation technology, UniStac, they are developing tri- or tetra-specific antibodies targeting NASH (Non-alcoholic steatohepatitis), immuno-oncology and fibrotic diseases.
Prazer Therapeutics, http://prazertx.com/. Founded 2019. Based in Seoul. Their SPiDEM technology, Selective protein degradation enabling moiety, is a novel platform to enhance bioavailability of SPiDEM-based drugs compared to other Targeted protein degradation techniques. They are working, among others, on Alzheimer’s disease, Parkinson’s disease, and Prostate cancer.
Standigm, https://www.standigm.com/. Founded 2015, located in Seoul. Artificial Intelligence Drug Discovery company. They recently announced finding “a new rheumatoid arthritis indication for an FDA-approved drug and have filed a patent”.
